Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products.


Updates from The Motley Fool

Latest updates on Novartis from Fool.com.


Stock Performance

NVS vs. S&P 500 | 2 Year Performance
View Interactive NVS Charts
Sponsored by

Key Data Points

Primary metrics and data points about Novartis.
Current Price: $81.10
Prev Close: $81.36
Open: $81.53
Bid: $81.07
Ask: $81.08
Day's Range: $80.90 - $81.59
52wk Range: $69.90 - $98.97
Volume: 627,999
Avg Vol 1,157,561
Market Cap: $194.31B
P/E (ttm): 21.99
EPS (ttm): $0.00
Div & Yield: $2.67 (2.8%)

Company Rating

What our community thinks about Novartis.
CAPS Rating 4 out of 5
 
1457 Outperform
44 Underperform
CAPS All Stars
 
378 Outperform
10 Underperform

How do you think Novartis will perform against the market?



You pick for Novartis is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Joseph Jimenez, CEO

81% Approve

Based on 64 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Novartis.

Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Drug Makers